HOME >> MEDICINE >> NEWS
Estrogen has antitumor activity in hormone therapy-resistant breast tumors

A pair of studies in the November 5 issue of the Journal of the National Cancer Institute suggest that low levels of estrogen--the same hormone that promotes breast cancer in its early stages--can shrink breast tumors that have developed resistance to the drugs tamoxifen and raloxifene.

Tamoxifen is a selective estrogen receptor modulator (SERM) used to treat estrogen receptor-positive breast cancers and prevent recurrence of the disease. However, tamoxifen often loses effectiveness over time and can subsequently stimulate breast cancer growth. New endocrine therapies, such as aromatase inhibitors and the antiestrogen fulvestrant, are being are used to augment the effects of tamoxifen, although some studies are suggesting that low levels of estrogen may also inhibit the growth of tamoxifen-stimulated breast tumors.

Clodia Osipo, Ph.D., and V. Craig Jordan, Ph.D., D.Sc., of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University in Chicago, and their colleagues examined the effect of tamoxifen, the estrogen estradiol, and fulvestrant, both alone and in various combinations, in a mouse model of tamoxifen-stimulated human breast cancer.

The researchers found that low levels of estradiol caused tamoxifen-resistant breast tumors to regress, apparently by increasing apoptosis (cell suicide) through decreased expression of Her2/neu and NF-κB, two factors that inhibit apoptosis, and increased expression of the death receptor protein Fas, which regulates apoptosis.

Combined treatment with fulvestrant plus estradiol unexpectedly promoted the growth of tamoxifen-stimulated breast tumors, suggesting that the use of fulvestrant in patients with sufficient levels of circulating estrogen may actually stimulate tumor growth.

In the second study, Hong Liu, M.D., Ph.D., of the Robert H. Lurie Comprehensive Cancer Center, Jordan, and their colleagues examined whether low doses of estradiol would also have an
'"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
31-Dec-2000


Page: 1 2

Related medicine news :

1. Estrogen-associated COX-2 pathways explain protection from heart disease in female mice
2. Estrogen or stimulating environment boost memory
3. Estrogenlike drugs may eventually help postmenopausal women with weight gain
4. Estrogen offers no overall benefit for disease prevention in postmenopausal women with hysterectomy
5. Estrogen makes the brain more vulnerable to stress
6. Estrogen replacement increases risk factors for arrhythmia and sudden death
7. Estrogen may lower womens risk of heart disease by working as damper on inflammation
8. Estrogen may dictate what problem-solving strategy brain uses
9. Testosterone may reduce risk of stroke in men; Estrogen levels not related to stroke
10. Estrogens role in preventing female cardiac disease
11. Estrogen shows potential as stroke treatment, UF animal studies show

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... (PRWEB) , ... February 19, 2019 , ... ... impact of weight stigma in pregnant and postpartum women, a team led by ... pregnancy and early postpartum often show increased depressive symptoms, greater weight gain during ...
(Date:2/19/2019)... ... February 19, 2019 , ... Pneumatic Vacuum Elevators, LLC has ... information on how-to make a house handicap accessible. , With this infographic ... a house handicap accessible. To accurately educate consumers on handicap accessibility, the ...
(Date:2/19/2019)... ... February 19, 2019 , ... Hospice of Westchester (HOW) is pleased ... will support the heart of its operation, the organization’s Home Care Services. , ... we are grateful for their ongoing generosity,” said Mary K. Spengler, MS, Chief Executive ...
(Date:2/19/2019)... ... February 19, 2019 , ... The California Dental Association is ... loan refinancing as a new member benefit. , Student loan debt is ... debt for all indebted graduates in the class of 2018 for public and ...
(Date:2/19/2019)... ... 2019 , ... NCPDP announced today that Dave deBronkart, ... deliver the luncheon keynote on Tuesday, May 7, at its 2019 Annual ... partnerships between patients and their medical providers to NCPDP’s Annual Conference, May 6-8, ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... ... February 19, 2019 , ... Clearwater Dental Associates is opening its doors for ... the proper amount of bone to support a dental implant long-term. Specifically, the team ... of the jaw bone. , Gum disease and untreated tooth loss commonly cause bone ...
(Date:2/19/2019)... ... 19, 2019 , ... Dr. Jacqueline Subka, a trusted and experienced dentist, welcomes ... an appointment at her Simi Valley office to discuss candidacy for placement of dental ... 20 years or longer with proper care and restore aesthetics and function to the ...
(Date:2/19/2019)... , ... February 19, 2019 , ... ... professional experiences with students from kindergarten through 6th grade at the school by ... life cycle, mosquito surveillance and control with an emphasis on what students can ...
Breaking Medicine Technology:
Cached News: